McNally EM - Search Results

1

Consequences of disrupting the dystrophin-sarcoglycan complex in cardiac and skeletal myopathy.

Heydemann A, McNally EM. Heydemann A, et al. Among authors: mcnally em. Trends Cardiovasc Med. 2007 Feb;17(2):55-9. doi: 10.1016/j.tcm.2006.12.002. Trends Cardiovasc Med. 2007. PMID: 17292047 Review.

2

Human epsilon-sarcoglycan is highly related to alpha-sarcoglycan (adhalin), the limb girdle muscular dystrophy 2D gene.

McNally EM, Ly CT, Kunkel LM. McNally EM, et al. FEBS Lett. 1998 Jan 23;422(1):27-32. doi: 10.1016/s0014-5793(97)01593-7. FEBS Lett. 1998. PMID: 9475163 Free article.

3

Gamma-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin.

Hack AA, Ly CT, Jiang F, Clendenin CJ, Sigrist KS, Wollmann RL, McNally EM. Hack AA, et al. Among authors: mcnally em. J Cell Biol. 1998 Sep 7;142(5):1279-87. doi: 10.1083/jcb.142.5.1279. J Cell Biol. 1998. PMID: 9732288 Free PMC article.

4

Muscle degeneration without mechanical injury in sarcoglycan deficiency.

Hack AA, Cordier L, Shoturma DI, Lam MY, Sweeney HL, McNally EM. Hack AA, et al. Among authors: mcnally em. Proc Natl Acad Sci U S A. 1999 Sep 14;96(19):10723-8. doi: 10.1073/pnas.96.19.10723. Proc Natl Acad Sci U S A. 1999. PMID: 10485893 Free PMC article.

5

Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin-glycoprotein complex.

Hack AA, Lam MY, Cordier L, Shoturma DI, Ly CT, Hadhazy MA, Hadhazy MR, Sweeney HL, McNally EM. Hack AA, et al. Among authors: mcnally em. J Cell Sci. 2000 Jul;113 ( Pt 14):2535-44. doi: 10.1242/jcs.113.14.2535. J Cell Sci. 2000. PMID: 10862711

6

Overexpression of gamma-sarcoglycan induces severe muscular dystrophy. Implications for the regulation of Sarcoglycan assembly.

Zhu X, Hadhazy M, Groh ME, Wheeler MT, Wollmann R, McNally EM. Zhu X, et al. Among authors: mcnally em. J Biol Chem. 2001 Jun 15;276(24):21785-90. doi: 10.1074/jbc.M101877200. Epub 2001 Apr 3. J Biol Chem. 2001. PMID: 11287429 Free article.

7

Cardiomyopathy in animal models of muscular dystrophy.

Heydemann A, Wheeler MT, McNally EM. Heydemann A, et al. Among authors: mcnally em. Curr Opin Cardiol. 2001 May;16(3):211-7. doi: 10.1097/00001573-200105000-00009. Curr Opin Cardiol. 2001. PMID: 11357018 Review.

8

Cardiomyopathy is independent of skeletal muscle disease in muscular dystrophy.

Zhu X, Wheeler MT, Hadhazy M, Lam MY, McNally EM. Zhu X, et al. Among authors: mcnally em. FASEB J. 2002 Jul;16(9):1096-8. doi: 10.1096/fj.01-0954fje. Epub 2002 May 8. FASEB J. 2002. PMID: 12039854

9

Zeta-sarcoglycan, a novel component of the sarcoglycan complex, is reduced in muscular dystrophy.

Wheeler MT, Zarnegar S, McNally EM. Wheeler MT, et al. Among authors: mcnally em. Hum Mol Genet. 2002 Sep 1;11(18):2147-54. doi: 10.1093/hmg/11.18.2147. Hum Mol Genet. 2002. PMID: 12189167

10

Cytoskeletal defects in cardiomyopathy.

McNally E, Allikian M, Wheeler MT, Mislow JM, Heydemann A. McNally E, et al. J Mol Cell Cardiol. 2003 Mar;35(3):231-41. doi: 10.1016/s0022-2828(03)00018-x. J Mol Cell Cardiol. 2003. PMID: 12676538 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

363 results

Search Page